170 related articles for article (PubMed ID: 19301646)
1. In vitro and in vivo gene silencing by TransKingdom RNAi (tkRNAi).
Xiang S; Keates AC; Fruehauf J; Yang Y; Guo H; Nguyen T; Li CJ
Methods Mol Biol; 2009; 487():147-60. PubMed ID: 19301646
[TBL] [Abstract][Full Text] [Related]
2. Transkingdom RNA interference (tkRNAi): a novel method to induce therapeutic gene silencing.
Nguyen TA; Fruehauf JH
Methods Mol Biol; 2009; 514():27-34. PubMed ID: 19048211
[TBL] [Abstract][Full Text] [Related]
3. TransKingdom RNA interference: a bacterial approach to challenges in RNAi therapy and delivery.
Keates AC; Fruehauf J; Xiang S; Li CJ
Biotechnol Genet Eng Rev; 2008; 25():113-27. PubMed ID: 21412352
[TBL] [Abstract][Full Text] [Related]
4. Short hairpin RNA-expressing bacteria elicit RNA interference in mammals.
Xiang S; Fruehauf J; Li CJ
Nat Biotechnol; 2006 Jun; 24(6):697-702. PubMed ID: 16699500
[TBL] [Abstract][Full Text] [Related]
5. Targeting tumor gene by shRNA-expressing Salmonella-mediated RNAi.
Guo H; Zhang J; Inal C; Nguyen T; Fruehauf JH; Keates AC; Li CJ
Gene Ther; 2011 Jan; 18(1):95-105. PubMed ID: 20811467
[TBL] [Abstract][Full Text] [Related]
6. Transkingdom RNA interference (tkRNAi) as a new delivery tool for therapeutic RNA.
Aigner A
Expert Opin Biol Ther; 2009 Dec; 9(12):1533-42. PubMed ID: 19769540
[TBL] [Abstract][Full Text] [Related]
7. Carbonate apatite-facilitated intracellularly delivered siRNA for efficient knockdown of functional genes.
Hossain S; Stanislaus A; Chua MJ; Tada S; Tagawa Y; Chowdhury EH; Akaike T
J Control Release; 2010 Oct; 147(1):101-8. PubMed ID: 20620182
[TBL] [Abstract][Full Text] [Related]
8. A study of the suppressive effect on human pancreatic adenocarcinoma cell proliferation and angiogenesis by stable plasmid-based siRNA silencing of c-Src gene expression.
Zhao X; Li DC; Zhao H; Li Z; Wang JX; Zhu DM; Zhou J; Cen JN
Oncol Rep; 2012 Mar; 27(3):628-36. PubMed ID: 22200682
[TBL] [Abstract][Full Text] [Related]
9. Gene silencing through RNA interference (RNAi) in vivo: strategies based on the direct application of siRNAs.
Aigner A
J Biotechnol; 2006 Jun; 124(1):12-25. PubMed ID: 16413079
[TBL] [Abstract][Full Text] [Related]
10. RNA interference in the mouse vascular endothelium by systemic administration of siRNA-lipoplexes for cancer therapy.
Santel A; Aleku M; Keil O; Endruschat J; Esche V; Durieux B; Löffler K; Fechtner M; Röhl T; Fisch G; Dames S; Arnold W; Giese K; Klippel A; Kaufmann J
Gene Ther; 2006 Sep; 13(18):1360-70. PubMed ID: 16625242
[TBL] [Abstract][Full Text] [Related]
11. Bacterial delivery of siRNAs: a new approach to solid tumor therapy.
Xu DQ; Zhang L; Kopecko DJ; Gao L; Shao Y; Guo B; Zhao L
Methods Mol Biol; 2009; 487():161-87. PubMed ID: 19301647
[TBL] [Abstract][Full Text] [Related]
12. [Experimental research of targeting hTERT gene inhibited in hepatocellular carcinoma therapy by RNA interference].
Zhang PH; Tu ZG; Yang MQ; Huang WF; Zou L; Zhou YL
Ai Zheng; 2004 Jun; 23(6):619-25. PubMed ID: 15191658
[TBL] [Abstract][Full Text] [Related]
13. Local and systemic delivery of siRNAs for oligonucleotide therapy.
Takeshita F; Hokaiwado N; Honma K; Banas A; Ochiya T
Methods Mol Biol; 2009; 487():83-92. PubMed ID: 19301643
[TBL] [Abstract][Full Text] [Related]
14. Polyethylenimine (PEI)/siRNA-mediated gene knockdown in vitro and in vivo.
Höbel S; Aigner A
Methods Mol Biol; 2010; 623():283-97. PubMed ID: 20217558
[TBL] [Abstract][Full Text] [Related]
15. In vivo gene silencing in solid tumors by targeted electrically mediated siRNA delivery.
Golzio M; Mazzolini L; Ledoux A; Paganin A; Izard M; Hellaudais L; Bieth A; Pillaire MJ; Cazaux C; Hoffmann JS; Couderc B; Teissié J
Gene Ther; 2007 May; 14(9):752-9. PubMed ID: 17344906
[TBL] [Abstract][Full Text] [Related]
16. Development of a novel nonviral gene silencing system that is effective both in vitro and in vivo by using a star-shaped block copolymer (star vector).
Mori T; Ishikawa A; Nemoto Y; Kambe N; Sakamoto M; Nakayama Y
Bioconjug Chem; 2009 Jun; 20(6):1262-9. PubMed ID: 19456093
[TBL] [Abstract][Full Text] [Related]
17. RNA interference (RNAi) in hematology.
Scherr M; Steinmann D; Eder M
Ann Hematol; 2004 Jan; 83(1):1-8. PubMed ID: 14574462
[TBL] [Abstract][Full Text] [Related]
18. High-throughput selection of effective RNAi probes for gene silencing.
Kumar R; Conklin DS; Mittal V
Genome Res; 2003 Oct; 13(10):2333-40. PubMed ID: 14525931
[TBL] [Abstract][Full Text] [Related]
19. Construction of simple and efficient DNA vector-based short hairpin RNA expression systems for specific gene silencing in mammalian cells.
Cheng TL; Chang WT
Methods Mol Biol; 2007; 408():223-41. PubMed ID: 18314586
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic potential of RNA interference against cancer.
Takeshita F; Ochiya T
Cancer Sci; 2006 Aug; 97(8):689-96. PubMed ID: 16863503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
